Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263).
Journal: Gynecologic oncology
Published: August 11, 2025
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol.
Journal: Gynecologic oncology
Published: August 04, 2025
Malignant Brenner tumor with extensive clear cell features: A valuable diagnostic lesson learned from molecular tumor profiling and AI-based tumor differential tool.
Journal: Gynecologic oncology reports
Published: July 14, 2025
The effect of intrawound vancomycin powder on surgical site infection in inguinal lymph node dissection: a randomized controlled trial pilot study.
Journal: Gynecologic oncology reports
Published: April 21, 2025
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278).
Journal: Gynecologic oncology
Published: January 10, 2025
Surgical Oncology Breast Fellowship Websites: A Critical Analysis of Accessibility and Content for Society of Surgical Oncology (SSO)-Approved Program Websites.
Journal: Journal of surgical education
Published: December 29, 2024
A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel.
Journal: Therapeutic advances in medical oncology
Published: December 20, 2024
A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer".
Journal: Future oncology (London, England)
Published: July 11, 2024
The effects of BRCA1 and 2 mutations on ovarian reserve and aging.
Journal: Fertility and sterility
Published: July 05, 2024
Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
Journal: Therapeutic advances in medical oncology
Published: May 21, 2024
Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers.
Journal: Journal of women's health (2002)
Published: March 15, 2024
Patient-reported outcomes in the subpopulation of patients with mismatch repair-deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG3031/RUBY trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 08, 2024
Last Updated: 09/26/2026